semaglutide osteoporosis Do GLP-1 Drugs Cause Bone Loss? New Research on Risk The GLP-1 bone health story

PLCAR L-Carnitine Base The purest form, with a neutral profile, ideal for minimalist capsule lines

These peptides are known for their ability to boost blood flow, repair tissue, reduce scalp inflammation, and help reactivate dormant follicles

Europe - Significant market driven by strong healthcare systems, increasing geriatric population, widespread adoption of novel antidiabetic drugs, and government-backed chronic disease management programs

This approval makes Eli Lillys oral GLP-1 receptor agonist, to be marketed as Foundayo, the second GLP-1 drug available in pill form, after Wegovy, which gained approval in December 2025